30593770|t|Interactions of polyunsaturated fatty acids with amyloid peptides Abeta40 and Abeta42.
30593770|a|Polyunsaturated fatty acids (PUFAs) are reported to exert beneficial effects in Alzheimer's disease. Some PUFAs are known to reduce amyloid-beta (Abeta) toxicity by promoting its degradation and clearance. Studies on the direct interactions of PUFAs with Abeta peptides are limited and contradictory. In this study, we report the interactions of fatty acids docosahexaenoic acid (DHA), eicosatetraenoic acid (EPA), alpha-linolenic acid (ALA), arachidonic acid (ARA), linoleic acid (LNA) and oleic acid (OA) with Abeta peptides by carrying out fluorescence based aggregation kinetic experiments, transmission electron microscopy and molecular docking studies. Our investigations demonstrate that all the fatty acids tested exhibit anti-aggregation properties by preventing both Abeta40 and Abeta42 fibrillogenesis (~16-84% inhibition). OA and DHA were identified as excellent inhibitors of Abeta40 or Abeta42 fibrillogenesis respectively (~84% and 81% inhibition at 25 muM). Molecular docking studies conducted, using the dimer and oligomer models of Abeta40 peptide, suggest that these fatty acids interact in the aggregation prone Phe19-Ala21 and the beta-turn region (Asp23-Lys28) whereas a similar study with Abeta42 dimer and oligomer models, indicate that the fatty acids were oriented in a hydrophobic region (Gln15, Leu16, Leu17 and Leu34). These results, suggest that DHA, EPA, ALA, ARA, LNA and OA are capable of directly interacting with both Abeta40 and Abeta42 peptides. These studies will have implications in developing potential therapeutics for Alzheimer's disease.
30593770	16	43	polyunsaturated fatty acids	Chemical	MESH:D005231
30593770	78	85	Abeta42	Gene	351
30593770	87	114	Polyunsaturated fatty acids	Chemical	MESH:D005231
30593770	116	121	PUFAs	Chemical	MESH:D005231
30593770	167	186	Alzheimer's disease	Disease	MESH:D000544
30593770	193	198	PUFAs	Chemical	MESH:D005231
30593770	219	231	amyloid-beta	Gene	351
30593770	233	238	Abeta	Gene	351
30593770	240	248	toxicity	Disease	MESH:D064420
30593770	331	336	PUFAs	Chemical	MESH:D005231
30593770	342	347	Abeta	Gene	351
30593770	433	444	fatty acids	Chemical	MESH:D005227
30593770	445	465	docosahexaenoic acid	Chemical	MESH:D004281
30593770	467	470	DHA	Chemical	MESH:D004281
30593770	473	494	eicosatetraenoic acid	Chemical	MESH:D001095
30593770	502	522	alpha-linolenic acid	Chemical	MESH:D017962
30593770	524	527	ALA	Chemical	MESH:D017962
30593770	530	546	arachidonic acid	Chemical	MESH:D016718
30593770	548	551	ARA	Chemical	MESH:D016718
30593770	554	567	linoleic acid	Chemical	MESH:D019787
30593770	578	588	oleic acid	Chemical	MESH:D019301
30593770	590	592	OA	Chemical	MESH:D019301
30593770	599	604	Abeta	Gene	351
30593770	790	801	fatty acids	Chemical	MESH:D005227
30593770	876	883	Abeta42	Gene	351
30593770	922	924	OA	Chemical	MESH:D019301
30593770	929	932	DHA	Chemical	MESH:D004281
30593770	987	994	Abeta42	Gene	351
30593770	1173	1184	fatty acids	Chemical	MESH:D005227
30593770	1299	1306	Abeta42	Gene	351
30593770	1352	1363	fatty acids	Chemical	MESH:D005227
30593770	1463	1466	DHA	Chemical	MESH:D004281
30593770	1473	1476	ALA	Chemical	MESH:D017962
30593770	1478	1481	ARA	Chemical	MESH:D016718
30593770	1491	1493	OA	Chemical	MESH:D019301
30593770	1552	1559	Abeta42	Gene	351
30593770	1648	1667	Alzheimer's disease	Disease	MESH:D000544
30593770	Negative_Correlation	MESH:D019787	351
30593770	Negative_Correlation	MESH:D017962	351
30593770	Negative_Correlation	MESH:D016718	351
30593770	Negative_Correlation	MESH:D005227	351
30593770	Negative_Correlation	MESH:D005231	351
30593770	Negative_Correlation	MESH:D005231	MESH:D000544
30593770	Negative_Correlation	MESH:D004281	MESH:D000544
30593770	Negative_Correlation	MESH:D019301	MESH:D000544
30593770	Negative_Correlation	MESH:D019301	351
30593770	Negative_Correlation	MESH:D004281	351
30593770	Negative_Correlation	MESH:D005231	MESH:D064420

